SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001169245-22-000075
Filing Date
2022-05-24
Accepted
2022-05-24 17:13:06
Documents
1
Period of Report
2022-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165342676547850.html 4  
1 FORM 4 wf-form4_165342676547850.xml 4 3572
  Complete submission text file 0001169245-22-000075.txt   5191
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30 MALVERN PA 19355
Business Address
Birchall Jonathan (Reporting) CIK: 0001892776 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38697 | Film No.: 22958017